Investigation of the effects of three conservative treatment methods on temporomandibular disorders

Not Applicable

Recruiting

• Conditions: Temporomandibular disorders.; Temporomandibular joint disorders; M26.6

• Registration Number: IRCT20211010052719N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 1 November 2021

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 30

Inclusion Criteria

Chronic orofacial pain (more than three months) with or without restriction in opening the mouth.
Diagnosis of Temporomandibular disorder (Axis I) based on the RDC / TMD diagnostic criteria.
History of no previous treatment for TMD during the last month.
Having natural dentition

Exclusion Criteria

Recent fracture of mandibular bone.
History of recent facial trauma
Congenital / developmental disorders of the jaw.
Systemic musculoskeletal disease.
Fibromyalgia.
Previous or current history of the cancer.
Skin lesions at the laser site.
Pregnancy.
Diagnosis of Temporomandibular disorder of articular origin based on the RDC / TMD diagnostic criteria.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Pain intensity. Timepoint: Before treatment, immediately after treatment, one month and three months after the end of treatment. Method of measurement: visual scale analogue (VAS).;Maximum mouth opening with NO assistance. Timepoint: Before treatment, immediately after treatment, one month and three months after the end of treatment. Method of measurement: By ruler in millimeters.;Right & left and anterior lateral movement of mandible. Timepoint: Before treatment, immediately after treatment, one month and three months after the end of treatment. Method of measurement: By ruler in millimeters.;Functional limitations of jaw. Timepoint: Before treatment, immediately after treatment, one month and three months after the end of treatment. Method of measurement: visual scale analogue (VAS).